iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) Covered Calls

iPath Series B S&P 500 VIX Short-Term Futures ETN is an exchange-traded note designed to provide exposure to the S&P 500 VIX Short-Term Futures Index Total Return. The firm offers a daily rolling long position in first and second month VIX futures contracts, reflecting market views on future volatility. As an unsecured debt obligation of Barclays Bank PLC, it provides a liquid tool for hedging or speculating on equity market stress over a short time horizon.

You can sell covered calls on iPath Series B S&P 500 VIX Short-Term Futures ETN to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for VXX (prices last updated Fri 4:16 PM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

The iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) is a volatility-linked instrument designed to track the performance of the VIX Index through futures contracts. Unlike an ETF, VXX is an exchange-traded note, representing a senior unsecured debt obligation issued by Barclays Bank PLC. It is specifically engineered to provide a tactical hedge against equity market declines, typically exhibiting a strong negative correlation with the S&P 500. However, due to its daily rolling mechanism, it is intended strictly for short-term use rather than long-term buy-and-hold strategies.

2026 Volatility Dynamics and Performance

In the first quarter of 2026, VXX experienced a significant period of "mean reversion" as markets stabilized following early-year geopolitical jitters. After reaching a local high near $40 in late March 2026, the note faced a sharp 11.4% decline in early April, closing at $30.77 on April 10, 2026. This downward pressure was fueled by the "volatility crush" as the VIX Index retreated toward the 19 level. Despite a 3-month performance gain of 19.50%, the note remains down over 61% on a 52-week basis, highlighting the persistent erosion caused by the roll yield in a contango-dominated futures market.

Financially, the note maintains a significant presence in the volatility space with approximately $614 million in assets under management (AUM) as of April 2026. Barclays continues to support the product with an expense ratio of 0.89%. For options traders, VXX remains one of the most active instruments in the world, with open interest exceeding 365,000 contracts in mid-April. Implied volatility remains high at 81.38%, providing ample premium for sophisticated traders utilizing "tail risk" hedging or volatility-selling strategies.

Competitive Landscape

The volatility market is dominated by a few specialized providers offering short-term, mid-term, and inverse exposure to the VIX. Key competitors include:

1. ProShares VIX Short-Term Futures ETF: A direct competitor that tracks the same S&P 500 VIX Short-Term Futures Index. They compete by offering a traditional ETF structure, which some institutional investors prefer over the ETN credit risk associated with Barclays.
2. ProShares VIX Mid-Term Futures ETF: A peer that focuses on the fourth through seventh month VIX futures. They compete for investors seeking a less volatile, "slower-decay" hedge that is less susceptible to the immediate price swings of the front-month contracts.
3. ProShares Ultra VIX Short-Term Futures ETF: A leveraged alternative providing 1.5x daily exposure to the index. They compete for aggressive speculators looking to maximize their returns during high-velocity market crashes, though they carry significantly higher decay risk.
4. SPDR S&P 500 ETF Trust: The ultimate "Inverse" peer. Most VXX traders utilize the note as a direct hedge against SPY positions, making the broad-market index the primary benchmark for assessing the effectiveness of a volatility-based protection strategy.

Strategic Outlook and Risk Factors

The firm is prioritizing "Transparency and Education" in 2026, frequently updating its prospectus to remind investors of the "Path Dependency" risk inherent in VIX-linked products. Strategic efforts are focused on maintaining deep liquidity at the primary exchange level, ensuring that large institutional blocks can be executed even during periods of extreme market stress. Management continues to emphasize that the note is not a direct investment in the "Spot VIX," but rather a reflection of the futures curve.

Looking toward the second half of 2026, the note is positioned as a critical monitor for the "Agentic AI" cycle. As AI-driven high-frequency trading accounts for an increasing share of market volume, VXX is expected to capture the rapid spikes in intraday realized volatility. However, unless a sustained "Black Swan" event occurs, the structural headwinds of the futures roll are expected to continue dragging on long-term performance through 2027. Investors are advised to use the note tactically, resetting exposure frequently to avoid the compounding effects of negative carry.

Want more examples? VXUS Covered Calls | VXZ Covered Calls